» Articles » PMID: 17720020

Polycystic Ovary Syndrome

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2007 Aug 28
PMID 17720020
Citations 477
Authors
Affiliations
Soon will be listed here.
Abstract

Polycystic ovary syndrome is a heterogeneous endocrine disorder that affects about one in 15 women worldwide. The major endocrine disruption is excessive androgen secretion or activity, and a large proportion of women also have abnormal insulin activity. Many body systems are affected in polycystic ovary syndrome, resulting in several health complications, including menstrual dysfunction, infertility, hirsutism, acne, obesity, and metabolic syndrome. Women with this disorder have an established increased risk of developing type 2 diabetes and a still debated increased risk of cardiovascular disease. The diagnostic traits of polycystic ovary syndrome are hyperandrogenism, chronic anovulation, and polycystic ovaries, after exclusion of other conditions that cause these same features. A conclusive definition of the disorder and the importance of the three diagnostic criteria relative to each other remain controversial. The cause of polycystic ovary syndrome is unknown, but studies suggest a strong genetic component that is affected by gestational environment, lifestyle factors, or both.

Citing Articles

Decreased miR-128-3p in serum exosomes from polycystic ovary syndrome induces ferroptosis in granulosa cells via the p38/JNK/SLC7A11 axis through targeting CSF1.

Lv Y, Han S, Sun F, Zhang Y, Qu X, Li H Cell Death Discov. 2025; 11(1):64.

PMID: 39966422 PMC: 11836375. DOI: 10.1038/s41420-025-02331-0.


Nicotinamide riboside supplementation ameliorates ovarian dysfunction in a PCOS mouse model.

Zhu Z, Lei M, Guo R, Xu Y, Zhao Y, Wei C J Ovarian Res. 2025; 18(1):9.

PMID: 39833950 PMC: 11749135. DOI: 10.1186/s13048-025-01596-4.


Prevalence and factors associated with non-alcoholic fatty liver disease among women with polycystic ovary syndrome.

Franciscatto M, Taniguchi J, Wohlenberg R, Riedi I, Oppermann K Rev Bras Ginecol Obstet. 2024; 46.

PMID: 39669304 PMC: 11637444. DOI: 10.61622/rbgo/2024rbgo81.


The effects of ketogenic diet on metabolic and hormonal parameters in patients with polycystic ovary syndrome: a systematic review and meta-analysis of clinical trials.

Eshaghhosseiny N, Ahmadi M, Izadi B, Vali M, Akbari M, Azari I J Diabetes Metab Disord. 2024; 23(2):1573-1587.

PMID: 39610476 PMC: 11599545. DOI: 10.1007/s40200-024-01441-3.


Risk of polycystic ovary syndrome: a population-based analysis of sociodemographic factors, healthcare access, health behaviors, and health status.

Alenzi E, Alqntash N, Almajed E, AlZabin A BMC Womens Health. 2024; 24(1):623.

PMID: 39580400 PMC: 11585150. DOI: 10.1186/s12905-024-03446-9.